{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:37:51Z","timestamp":1762004271244},"reference-count":57,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The presence of antiphospholipid antibodies has been associated with an increased risk of recurrent pregnancy loss, and there is evidence to suggest that antithrombotic therapy improves the likelihood of a successful outcome in affected women. Recent studies suggest an association between hereditary thrombophilia and pregnancy loss, although a causal role remains controversial. Although the available data are limited and flawed, there is increasing use of antithrombotic therapy in thrombophilic women with a history of pregnancy failure. Given the absence of proven effective therapy in women with unexplained recurrent loss, there is also growing pressure to intervene with antithrombotics in women with no known underlying thrombophilia. This article reviews the evidence for an association between thrombophilia and recurrent pregnancy loss and the data regarding the use of antithrombotic therapy for prevention of loss\u2014an area that remains particularly challenging because of the paucity of good quality data upon which to base clinical decisions.<\/jats:p>","DOI":"10.1182\/asheducation-2010.1.166","type":"journal-article","created":{"date-parts":[[2011,1,16]],"date-time":"2011-01-16T19:08:48Z","timestamp":1295204928000},"page":"166-172","update-policy":"http:\/\/dx.doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["Consultative Hematology: The Pregnant Patient Pregnancy Loss"],"prefix":"10.1182","volume":"2010","author":[{"given":"Shannon M.","family":"Bates","sequence":"first","affiliation":[{"name":"Department of Medicine, McMaster University & Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111715453312800_B1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"2019111715453312800_B2","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1093\/humrep\/dei167","article-title":"Updated and revised nomenclature for description of early pregnancy events","volume":"20","author":"Farquharson","year":"2005","journal-title":"Hum Reprod"},{"key":"2019111715453312800_B3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage: definition and epidemiology","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"key":"2019111715453312800_B4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1053\/beog.2000.0123","article-title":"Epidemiology and the medical causes of miscarriage","volume":"14","author":"Regan","year":"2000","journal-title":"Baillieres Best Pract Res Clin Obstet Gynaecol"},{"key":"2019111715453312800_B5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/01674820209074668","article-title":"Psychiatric morbidity among patients with recurrent miscarriage","volume":"23","author":"Craig","year":"2002","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"2019111715453312800_B6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0049-3848(03)00095-1","article-title":"Thrombophilia: implications for pregnancy outcome","volume":"109","author":"Greer","year":"2003","journal-title":"Thromb Res"},{"key":"2019111715453312800_B7","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.96.14.8138","article-title":"Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation","volume":"96","author":"Erlich","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715453312800_B8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nm825","article-title":"The thrombomodulin-protein C system is essential for maintenance of pregnancy","volume":"9","author":"Isermann","year":"2003","journal-title":"Nat Med"},{"key":"2019111715453312800_B9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI3011","article-title":"Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice","volume":"102","author":"Jalbert","year":"1998","journal-title":"J Clin Invest"},{"key":"2019111715453312800_B10","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1182\/blood-2005-01-0406","article-title":"Extraembryonic expression of EPCR is essential for embryonic viability","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"key":"2019111715453312800_B11","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2005-10-4111","article-title":"Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells","volume":"107","author":"Sood","year":"2006","journal-title":"Blood"},{"key":"2019111715453312800_B12","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(05)60080-3","article-title":"Action of anticardiolin and antibodies to \u03b22-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death","volume":"352","author":"Chamley","year":"1998","journal-title":"Lancet"},{"key":"2019111715453312800_B13","first-page":"258","article-title":"Placental pathology, antiphospholipid antibodies and pregnancy outcome in recurrent miscarriage patients","volume":"101","author":"Sebire","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2019111715453312800_B14","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1073\/pnas.90.14.6464","article-title":"Anticardiolipin antibodies induce pregnancy failure by impairing embryonic implantation","volume":"90","author":"Sthoeger","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111715453312800_B15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2019111715453312800_B16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/14.2.489","article-title":"Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome","volume":"14","author":"Di Simone","year":"1999","journal-title":"Hum Reprod"},{"key":"2019111715453312800_B17","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1093\/humrep\/dem201","article-title":"Effect of heparin and unfractionated heparin on trophoblast invasion","volume":"22","author":"Ganapathy","year":"2007","journal-title":"Hum Reprod"},{"key":"2019111715453312800_B18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"2019111715453312800_B19","first-page":"2214","article-title":"Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a meta-analysis","volume":"33","author":"Opatrny","year":"2006","journal-title":"J Rheumatol"},{"key":"2019111715453312800_B20","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/oxfordjournals.humrep.a135907","article-title":"High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies","volume":"10","author":"Rai","year":"1995","journal-title":"Hum Reprod"},{"key":"2019111715453312800_B21","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0140-6736(03)12771-7","article-title":"Thrombophilic disorders and fetal loss: a meta-analysis","volume":"361","author":"Rey","year":"2003","journal-title":"Lancet"},{"key":"2019111715453312800_B22","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2005.01581.x","article-title":"Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control \u2018NOHA first\u2019 study","volume":"3","author":"Lissalde-Lavigne","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111715453312800_B23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/01.AOG.0000173986.32528.ca","article-title":"The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus","volume":"106","author":"Dizon-Townson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2019111715453312800_B24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3181c88918","article-title":"Prothrombin gene G20210A mutation and obstetric complications","volume":"115","author":"Silver","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2019111715453312800_B25","doi-asserted-by":"crossref","first-page":"e1000292","DOI":"10.1371\/journal.pmed.1000292","article-title":"The association of factor V Leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies","volume":"7","author":"Rodger","year":"2010","journal-title":"PLoS Med"},{"key":"2019111715453312800_B26","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1538-7836.2004.00662.x","article-title":"Hereditary thrombophilia and fetal loss: a prospective follow-up study","volume":"2","author":"Vossen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"2019111715453312800_B27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(65)90518-1","article-title":"Placental transport of heparin","volume":"93","author":"Flessa","year":"1965","journal-title":"Am J Obstet Gynecol"},{"key":"2019111715453312800_B28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","article-title":"Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound","volume":"34","author":"Forestier","year":"1984","journal-title":"Thromb Res"},{"key":"2019111715453312800_B29","first-page":"1319","article-title":"Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review","volume":"101","author":"Coomarasamy","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2019111715453312800_B30","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2019111715453312800_B31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.327.7411.368","article-title":"Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population-based cohort study","volume":"327","author":"Li","year":"2003","journal-title":"Br Med J"},{"key":"2019111715453312800_B32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/OGX.0b013e31815e8731","article-title":"Aspirin and reproductive outcomes","volume":"63","author":"James","year":"2007","journal-title":"Obstet Gynecol Survey"},{"key":"2019111715453312800_B33","doi-asserted-by":"crossref","first-page":"340S","DOI":"10.1378\/chest.08-0677","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Warkentin","year":"2008","journal-title":"Chest"},{"key":"2019111715453312800_B34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MCP.0b013e3283061191","article-title":"Heparin-induced osteoporosis and pregnancy","volume":"14","author":"Le Templier","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"2019111715453312800_B35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low molecular weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"2019111715453312800_B36","first-page":"140","article-title":"Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion","volume":"158","author":"Stray-Pedersen","journal-title":"Am J Obstet Gynecol"},{"key":"2019111715453312800_B37","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1182\/blood-2010-01-267252","article-title":"The Scottish Pregnancy Intervention Study: a multicenter randomized controlled trial of low molecular weight heparin and low dose aspirin in women with recurrent miscarriage","volume":"115","author":"Clark","year":"2010","journal-title":"Blood"},{"key":"2019111715453312800_B38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/01443610802042688","article-title":"Low molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology","volume":"38","author":"Badawy","year":"2008","journal-title":"J Obstet Gynecol"},{"key":"2019111715453312800_B39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"2019111715453312800_B40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111715453312800_B41","first-page":"CD00285","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst. Rev"},{"key":"2019111715453312800_B42","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200209000-00004","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"2019111715453312800_B43","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"2019111715453312800_B44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"Br Med J"},{"key":"2019111715453312800_B45","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2019111715453312800_B46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"2019111715453312800_B47","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"2019111715453312800_B48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2019111715453312800_B49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"2019111715453312800_B50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"2019111715453312800_B51","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology"},{"key":"2019111715453312800_B52","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"2019111715453312800_B53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1538-7836.2004.01090.x","article-title":"Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study","volume":"3","author":"Brenner","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2019111715453312800_B54","doi-asserted-by":"crossref","first-page":"844S","DOI":"10.1378\/chest.08-0761","article-title":"Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Bates","year":"2008","journal-title":"Chest"},{"key":"2019111715453312800_B55","unstructured":"Royal College of Obstetricians and Gynaecologists\n          The investigation and treatment of couples with recurrent miscarriages (Green-top Guideline No. 17)\n          Accessed April 29, 2010\n          \n            http:\/\/www.rcog.org.uk\/womens-health\/clinical-guidance\/investigation-and-treatment-couples-recurrent-miscarriage-green-top. Revised May 1 2003"},{"key":"2019111715453312800_B56","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN)\n          Guideline No. 62: prophylaxis of venous thromboembolism. Section 9: pregnancy and the puerperium\n          Accessed April 29, 2010\n          \n            http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/62\/. Published October 2002"},{"key":"2019111715453312800_B57","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2141.2009.08022.x","article-title":"Clinical guidelines for testing for heritable thrombophilia","volume":"149","author":"Baglin","year":"2010","journal-title":"Br J Haematol"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/166\/1493097\/bep00110000166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2010\/1\/166\/1493097\/bep00110000166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T20:45:58Z","timestamp":1574023558000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2010\/1\/166\/96393\/Consultative-Hematology-The-Pregnant-Patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,4]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12,4]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2010.1.166","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,4]]}}}